Zoekresultaten - Matthias Scheffler

Verfijn jouw resultaten
  1. 1
    On target: Rational approaches to KRAS inhibition for treatment of non-small cell lung carcinoma

    On target: Rational approaches to KRAS inhibition for treatment of non-small cell lung carcinoma door Colin R. Lindsay, Marina Chiara Garassino, Ernest Nadal, Katarina Öhrling, Matthias Scheffler, Julien Mazières

    Gepubliceerd in 2021
    Volledige tekst Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  2. 2
    Comprehensive Analysis of TP53 and KEAP1 Mutations and Their Impact on Survival in Localized- and Advanced-Stage NSCLC

    Comprehensive Analysis of TP53 and KEAP1 Mutations and Their Impact on Survival in Localized- and Advanced-Stage NSCLC door Mohamed Mahde Saleh, Matthias Scheffler, Sabine Merkelbach‐Bruse, Andreas H. Scheel, Bastian Ulmer, Jürgen Wolf, Reinhard Buettner

    Gepubliceerd in 2021
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  3. 3
    Multiple Sclerosis: MicroRNA Expression Profiles Accurately Differentiate Patients with Relapsing-Remitting Disease from Healthy Controls

    Multiple Sclerosis: MicroRNA Expression Profiles Accurately Differentiate Patients with Relapsing-Remitting Disease from Healthy Controls door Andreas Keller, Petra Leidinger, Julia Lange, Anne Borries, Hannah Schroers, Matthias Scheffler, Hans‐Peter Lenhof, Klemens Ruprecht, Eckart Meese

    Gepubliceerd in 2009
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  4. 4
    Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon <i>EGFR</i> Mutations Pretreated With Reversible EGFR Inhibitors

    Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon <i>EGFR</i> Mutations Pretreated With Reversible EGFR Inhibitors door David F. Heigener, Christian Schumann, Martin Sebastian, Parvis Sadjadian, Ingo Stehle, Angela Märten, A Lüers, Frank Griesinger, Matthias Scheffler

    Gepubliceerd in 2015
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  5. 5
    miRNAs in lung cancer - Studying complex fingerprints in patient's blood cells by microarray experiments

    miRNAs in lung cancer - Studying complex fingerprints in patient's blood cells by microarray experiments door Andreas Keller, Petra Leidinger, Anne Borries, Anke Wendschlag, Frank Wucherpfennig, Matthias Scheffler, Hanno Huwer, Hans‐Peter Lenhof, Eckart Meese

    Gepubliceerd in 2009
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  6. 6
    Quantitative Analysis of Response to Treatment with Erlotinib in Advanced Non–Small Cell Lung Cancer Using <sup>18</sup>F-FDG and 3′-Deoxy-3′-<sup>18</sup>F-Fluorothymidine PET

    Quantitative Analysis of Response to Treatment with Erlotinib in Advanced Non–Small Cell Lung Cancer Using <sup>18</sup>F-FDG and 3′-Deoxy-3′-<sup>18</sup>F-Fluorothymidine PET... door Deniz Kahraman, Matthias Scheffler, Thomas Zander, Lucia Nogová, Adriaan A. Lammertsma, Ronald Boellaard, Bernd Neumaier, Roland T. Ullrich, Arne Holstein, Markus Dietlein, Jürgen Wolf, Carsten Kobe

    Gepubliceerd in 2011
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  7. 7
    Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening

    Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening door Sebastian Häusler, Andreas Keller, P. Anoop Chandran, Kerstin Ziegler, K Zipp, Stefan Heuer, Mathias Krockenberger, J. Engel, A Hönig, Matthias Scheffler, J. Dietl, Jörg Wischhusen

    Gepubliceerd in 2010
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  8. 8
    Exploring the conformational preferences of 20-residue peptides in isolation: Ac-Ala<sub>19</sub>-Lys + H<sup>+</sup>vs. Ac-Lys-Ala<sub>19</sub> + H<sup>+</sup> and the current reach of DFT

    Exploring the conformational preferences of 20-residue peptides in isolation: Ac-Ala<sub>19</sub>-Lys + H<sup>+</sup>vs. Ac-Lys-Ala<sub>19</sub> + H<sup>+</sup> and the current rea... door Franziska Schubert, Mariana Rossi, Carsten Baldauf, Kevin Pagel, Stephan Warnke, Gert von Helden, Frank Filsinger, Peter Kupser, Gerard Meijer, Mario Salwiczek, Beate Koksch, Matthias Scheffler, Volker Blüm

    Gepubliceerd in 2015
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  9. 9
    A plasma metabolite panel as biomarkers for early primary breast cancer detection

    A plasma metabolite panel as biomarkers for early primary breast cancer detection door Baowen Yuan, Simon Schafferer, Qiuqiong Tang, Matthias Scheffler, Juliane Nees, Jörg Heil, Sarah Schott, Michael Golatta, Markus Wallwiener, Christof Sohn, Therese Koal, Barbara Wolf, Andreas Schneeweiß, Barbara Burwinkel

    Gepubliceerd in 2018
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  10. 10
    Natalizumab restores aberrant mi<scp>RNA</scp>expression profile in multiple sclerosis and reveals a critical role for miR‐20b

    Natalizumab restores aberrant mi<scp>RNA</scp>expression profile in multiple sclerosis and reveals a critical role for miR‐20b door Jens Ingwersen, Til Menge, Britta Wingerath, Derya Kaya, Jonas Graf, Tim Prozorovski, Andreas Keller, Christina Backes, Markus Beier, Matthias Scheffler, Thomas Dehmel, Bernd C. Kieseier, Hans‐Peter Hartung, Patrick Küry, Orhan Aktaş

    Gepubliceerd in 2014
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  11. 11
    KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC

    KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC door Christoph Arolt, Margaret Dugan, Robert Wild, Vanessa Richartz, Barbara Holz, Andreas H. Scheel, Johannes Brägelmann, Svenja Wagener‐Ryczek, Sabine Merkelbach‐Bruse, Juergen Wolf, Reinhard Buettner, Luigi Catanzariti, Matthias Scheffler, Axel M. Hillmer

    Gepubliceerd in 2023
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  12. 12
    Fully Automated <scp>MR</scp> Detection and Segmentation of Brain Metastases in Non‐small Cell Lung Cancer Using Deep Learning

    Fully Automated <scp>MR</scp> Detection and Segmentation of Brain Metastases in Non‐small Cell Lung Cancer Using Deep Learning door Stephanie T. Jünger, Ulrike Cornelia Isabel Hoyer, Diana Schaufler, Kai Roman Laukamp, Lukas Goertz, Frank Thiele, Jan‐Peter Grunz, Marc Schlamann, Michael Perkuhn, Christoph Kabbasch, Thorsten Persigehl, Stefan Grau, Jan Borggrefe, Matthias Scheffler, Rahil Shahzad, Lenhard Pennig

    Gepubliceerd in 2021
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  13. 13
    PD-L1 expression in non-small cell lung cancer: Correlations with genetic alterations

    PD-L1 expression in non-small cell lung cancer: Correlations with genetic alterations door Andreas H. Scheel, Sascha Ansén, Anne M. Schultheis, Matthias Scheffler, Rieke Fischer, Sebastian Michels, Martin Hellmich, Julie George, Thomas Zander, Michael Brockmann, Erich Stoelben, Harry J.M. Groen, Wim Timens, Sven Perner, Michael von Bergwelt‐Baildon, Reinhard Büttner, Jürgen Wolf

    Gepubliceerd in 2016
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  14. 14
    Benchmarking of Mutation Diagnostics in Clinical Lung Cancer Specimens

    Benchmarking of Mutation Diagnostics in Clinical Lung Cancer Specimens door Silvia Querings, Janine Altmüller, Sascha Ansén, Thomas Zander, Danila Seidel, Franziska Gabler, Martin Peifer, Eva Markert, Kathryn Stemshorn, Bernd Timmermann, Beate Saal, Stefan M. Klose, Karen Ernestus, Matthias Scheffler, Walburga Engel-Riedel, Erich Stoelben, Élisabeth Brambilla, Jürgen Wolf, Peter Nürnberg, Roman K. Thomas

    Gepubliceerd in 2011
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  15. 15
    Clinical and Pathological Characteristics of <i>KEAP1</i>- and <i>NFE2L2</i>-Mutated Non–Small Cell Lung Carcinoma (NSCLC)

    Clinical and Pathological Characteristics of <i>KEAP1</i>- and <i>NFE2L2</i>-Mutated Non–Small Cell Lung Carcinoma (NSCLC) door Rieke Frank, Matthias Scheffler, Sabine Merkelbach‐Bruse, Michaela A. Ihle, Anna Kron, Michael Rauer, Rebecca Roth, Katharina König, Sebastian Michels, Rieke Fischer, Anna Eisert, Jana Fassunke, Carina Heydt, Monika Serke, Yon‐Dschun Ko, Ulrich Gerigk, Thomas Geist, Britta Kaminsky, Lukas C. Heukamp, Mathieu Clément‐Ziza, Reinhard Büttner, Jürgen Wolf

    Gepubliceerd in 2018
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  16. 16
    Evaluation of the effectiveness of a nationwide precision medicine program for patients with advanced non-small cell lung cancer in Germany: a historical cohort analysis

    Evaluation of the effectiveness of a nationwide precision medicine program for patients with advanced non-small cell lung cancer in Germany: a historical cohort analysis door Anika Kästner, Anna Kron, Neeltje van den Berg, Kilson Moon, Matthias Scheffler, Gerhard Schillinger, Natalie Pelusi, Nils Hartmann, Damian Rieke, Susann Stephan-Falkenau, Martin Schüler, Martin Wermke, Wilko Weichert, Frederick Klauschen, Florian Haller, Horst-Dieter Hummel, Martin Sebastian, Stefan Gattenlöhner, Carsten Bokemeyer, Iréne Esposito, Florian Jakobs, Christof von Kalle, Reinhard Büttner, Jürgen Wolf, Wolfgang Hoffmann

    Gepubliceerd in 2023
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  17. 17
    Targeted Therapy for Patients with BRAF-Mutant Lung Cancer Results from the European EURAF Cohort

    Targeted Therapy for Patients with BRAF-Mutant Lung Cancer Results from the European EURAF Cohort door Oliver Gautschi, Julie Milia, Bastien Cabarrou, M.V. Bluthgen, Benjamin Besse, Egbert F. Smit, Juergen Wolf, Solange Peters, Martin Früh, Dieter Koeberle, Youssouf Oulkhouir, Martin Schüler, Alessandra Curioni‐Fontecedro, Benjamin Huret, M. Kerjouan, Sebastian Michels, Georg Pall, Sacha I. Rothschild, Gerald Schmid‐Bindert, Matthias Scheffler, Rémi Veillon, Luciano Wannesson, Joachim Diebold, Gérard Zalcman, Thomas Filleron, Julien Mazières

    Gepubliceerd in 2015
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  18. 18
    <i>ROS1</i> rearrangements in lung adenocarcinoma: prognostic impact, therapeutic options and genetic variability

    <i>ROS1</i> rearrangements in lung adenocarcinoma: prognostic impact, therapeutic options and genetic variability door Matthias Scheffler, Anne M. Schultheis, Cristina Teixidó, Sebastian Michels, Daniela Morales-Espinosa, Santiago Viteri, Wolfgang Hartmann, Sabine Merkelbach‐Bruse, Rieke Fischer, Hans‐Ulrich Schildhaus, Jana Fassunke, Martin Sebastian, Monika Serke, Britta Kaminsky, Winfried Randerath, Ulrich Gerigk, Yon‐Dschun Ko, Stefan Krüger, Roland Schnell, Achim Rothe, Cornelia Kropf-Sanchen, Lukas C. Heukamp, Rafael Rosell, Reinhard Büttner, Jürgen Wolf

    Gepubliceerd in 2015
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  19. 19
    Early Prediction of Nonprogression in Advanced Non–Small-Cell Lung Cancer Treated With Erlotinib By Using [<sup>18</sup>F]Fluorodeoxyglucose and [<sup>18</sup>F]Fluorothymidine Positron Emission Tomography

    Early Prediction of Nonprogression in Advanced Non–Small-Cell Lung Cancer Treated With Erlotinib By Using [<sup>18</sup>F]Fluorodeoxyglucose and [<sup>18</sup>F]Fluorothymidine Pos... door Thomas Zander, Matthias Scheffler, Lucia Nogová, Carsten Kobe, Walburga Engel-Riedel, Martin Hellmich, Irini Papachristou, Karin Toepelt, Andreas Draube, Lukas C. Heukamp, Reinhard Buettner, Yon Ko, Roland T. Ullrich, Egbert F. Smit, Ronald Boellaard, Adriaan A. Lammertsma, Michael Hallek, Andreas H. Jacobs, Andreas Schlesinger, Karin Schulte, Silvia Querings, Erich Stoelben, Bernd Neumaier, Roman K. Thomas, Markus Dietlein, Jürgen Wolf

    Gepubliceerd in 2011
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  20. 20
    Treatment Monitoring of Immunotherapy and Targeted Therapy Using <sup>18</sup>F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences

    Treatment Monitoring of Immunotherapy and Targeted Therapy Using <sup>18</sup>F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences door Norbert Galldiks, Diana S.Y. Abdulla, Matthias Scheffler, Fabian Wolpert, Jan‐Michael Werner, Martin Hüllner, Gabriele Stoffels, Viola Schweinsberg, Max Schlaak, Nicole Kreuzberg, Jennifer Landsberg, Philipp Lohmann, Garry Ceccon, Christian Baues, Maike Trommer, Eren Celik, Maximilian I. Ruge, Martin Köcher, Simone Marnitz, Gereon R. Fink, Jörg‐Christian Tonn, Michael Weller, Karl‐Josef Langen, Jürgen Wolf, Cornelia Mauch

    Gepubliceerd in 2020
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:

Zoekinstrumenten: